What is Mettler-Toledo International Inc (MTD)?
Mettler-Toledo International Inc trades as MTD on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-11-07.
Is MTD in a Closelooknet index?
Not currently — Mettler-Toledo International Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-07.
Where does MTD trade against its moving averages?
Mettler-Toledo International Inc trades 13.0% above its 50-day and 28.2% above its 200-day moving average (3.5% above its 20-day). As of 2026-11-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.
How does Mettler-Toledo International Inc compare with its peers?
Against its peer group (Diagnostics & Research · United States), Mettler-Toledo International Inc (MTD) sits 4.7% below its 52-week high, 13.0% above its 50-day average; Labcorp Holdings Inc. (LH) is 1.8% below, Charles River Laboratories (CRL) is 11.1% below, Qiagen NV (QGEN) is 13.0% below, as of 2026-11-06. Put any of them next to MTD in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.
How does Mettler-Toledo International Inc trade when bond yields rise?
Over the past year Mettler-Toledo International Inc had a beta of 0.74 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 66% of US names. On the 10 sessions in which long bonds fell most it moved −0.19% on average, against −0.74% for the S&P 500. As of 2026-11-06; The "How it trades on rate days" block on this page carries the lines.
Where has Closelooknet written about Mettler-Toledo International Inc?
Mettler-Toledo International Inc appears in 1 Closelooknet piece as of 2026-11-07, most recently Daily Pulse: Friday flips broadly risk-off — Korea −6.1%, Temperature still 57 (2026-05-18). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.
What does Mettler-Toledo International Inc do?
Mettler-Toledo makes precision instruments used in laboratories, factories and shops: balances, pipettes, titrators, pH meters, spectrophotometers, moisture analysers and industrial weighing and inspection equipment such as scales, metal detectors and x-ray checkweighers. It also sells software, including a platform called LabX, that runs alongside its instruments to manage data and automate testing. Customers span pharmaceutical and biotech firms, food producers and retailers, chemical companies, and logistics and electronics businesses. The diary has no set peer group for this name in our records; the comparison the market draws most often is with Thermo Fisher Scientific and Danaher, both broader life-science instrument suppliers. (Company snapshot of 2026-09-17.)
Where does Mettler-Toledo International Inc sit in the AI build-out?
Mettler-Toledo carries no seat in our Rubin index, so it sits outside the AI build-out stack; the diary places it in the Diagnostics & Research part of the Healthcare sector, where it supplies measurement instruments rather than compute infrastructure. It holds a seat in the S&P 500, which is the only Closelooknet index seat recorded for it; no Closelooknet score has been built for the name yet. (Company snapshot of 2026-09-17.)
What has Wall Street done on Mettler-Toledo International Inc recently?
The most recent analyst action on Mettler-Toledo International Inc on the Closelooknet wire is a price target by Jefferies on 2026-11-06 (target 1,930). 2 actions on the analyst wire since 2026-08-13: 2 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.
What does this page show?
A live price chart with SMA overlays and drawing tools for MTD, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.